查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1923016

半刚性环状成形术环市场（按材质类型、应用和最终用户划分）—2026-2032年全球预测

Semi-Rigid Annuloplasty Ring Market by Material Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年半刚性环状成形术环市值为 3.0502 亿美元，预计到 2026 年将成长至 3.2583 亿美元，预计到 2032 年将达到 4.9231 亿美元，复合年增长率为 7.07%。

关键市场统计数据
基准年 2025 3.0502亿美元
预计年份：2026年 3.2583亿美元
预测年份 2032 4.9231亿美元
复合年增长率 (%) 7.07%

半刚性环状成形术环在现代瓣膜修復中发挥着至关重要的作用，它提供必要的机械支撑和贴合性，在恢復瓣环几何结构的同时，也能维持瓣叶的动态运动。在二尖瓣和三尖瓣修復中，这些装置兼顾了结构加固和生理柔软性，使外科医生能够根据退化性、缺血性和功能性疾病状态来製定修復策略。过去十年，在支持持久疗效和保留原生瓣膜解剖结构的证据推动下，临床医生越来越倾向于尽可能采用修復方法。因此，兼顾耐用性和血流动力学性能的装置设计变得日益重要。

从商业性角度来看，产品开发趋势强调模组化、材料科学以及输送和植入流程的渐进式创新。製造商正积极回应外科医生的回馈，设计出能够简化尺寸选择、实现牢固固定并支援微创入路的器械。随着医院和心臟中心采用混合手术室模式并投资先进的影像技术，器械的互通性和手术效率正成为重要的差异化因素。因此，对于希望在复杂的医疗环境中加速器材应用并展现其价值的医疗设备团队、采购经理和临床领导者而言，了解器材选择背后的临床需求、手术流程以及相关人员的奖励至关重要。

临床实务、监管路径和器材创新方面的变革性变化正在改变环状成形术环修復策略和商业性格局。

半刚性环状成形术环的市场格局正经历变革，这主要受临床、技术和政策因素的共同驱动。微创手术技术和术中影像技术的进步扩大了符合修復条件的患者群体，并改变了瓣膜成形环设计必须应对的手术操作效率。同时，经导管瓣膜治疗和混合疗法的成熟推动了对能够与导管介入工作流程整合并能与经皮支撑装置互补的器械的需求。因此，为了满足外科医生的偏好，研发人员优先考虑低轮廓设计、放射性标记以及与内视镜和机器人平台的兼容性。

2025年美国关税对心臟植入製造商的设备供应链、采购经济效益与策略采购决策的累积影响

美国于2025年实施并逐步收紧关税，对半刚性环状成形术环的製造商和供应商产生了连锁的营运和战略影响。关税带来的成本压力迫使采购部门重新评估零件来源和生产地，促使他们采取近岸外包、双重采购和选择性供应商整合等策略来降低风险。同时，製造商实施了库存套期保值，并重新谈判了长期供应合同，以稳定投入成本并维持利润率。这些措施对前置作业时间产生了间接影响，一些公司延长了计划週期，而其他公司则接受了更高的库存维修成本，以避免组装中断。

对临床应用、通路、终端用户画像和材料选择进行細項分析，可为推动产品采纳、采购和设备设计提供洞察。

細項分析揭示了不同临床应用、通路、终端用户环境和材料选择的需求驱动因素和设计优先顺序。在应用细分方面，二尖瓣和三尖瓣修復在手术复杂性和临床终点方面存在差异。二尖瓣修復通常区分初次手术和二次手术，三尖瓣修復也存在类似的初次手术与二次手术之分。这会影响瓣环尺寸选择演算法、固定策略和术中器械。这些临床因素既影响设计规范，也影响外科医师训练需求，从而形成以植入便利性和术中适应性为决定性因素的细分市场。

影响美洲、欧洲、中东和非洲以及亚太地区医疗保健市场商业化和应用的区域趋势和临床基础设施

区域趋势塑造着临床实践模式、采购标准以及医疗器材开发商必须遵循的法规结构。在美洲，三级心臟中心的手术量集中以及强大的私立医院体系影响着新产品上市的时机以及外科医生意见领袖在技术推广中的作用。同时，北美和拉丁美洲市场的供应链网路和报销模式产生了微妙的需求讯号，开发人员必须解读这些讯号以调整培训投入和商业性覆盖策略。在欧洲、中东和非洲地区，监管协调工作与各国特定的卫生技术评估流程并存，迫使企业采用差异化的证据产生计画和区域性打入市场策略。

领先的心臟设备开发商的竞争格局和企业策略将如何影响创新、伙伴关係模式和製造地

半刚性环状成形术环领域的主要企业正采取互补策略，结合有针对性的研发、选择性併购以及与临床中心的伙伴关係，以加速实证医学证据的累积和手术推广。投资于材料科学和迭代设计改进的企业，透过更低轮廓的器械、更完善的固定係统以及简化微创植入流程的功能，实现差异化竞争优势。同时，战略许可协议和OEM伙伴关係使一些企业能够在无需承担地域扩张所需全部资本的情况下，扩大生产规模并拓展分销渠道。

为产业领导者提供切实可行的建议，以调整研发方向、加强供应链并改变商业模式，从而适应不断变化的临床和政策环境。

行业领导者应优先考虑切实可行的措施，将临床价值与营运韧性和商业性灵活性相结合。首先，透过重点关注与外科医生和支付方最相关的手术终点的前瞻性註册研究和合作主导的研究，推动证据的产生。将真实世界的临床结果与卫生经济学见解相结合，将增强合约谈判能力，并扩大与支付方的谈判平台。其次，实现供应商多元化，确保关键零件的替代来源，同时探索近岸外包方案，以降低关税和地缘政治风险。合约结构应包含数量波动条款和紧急条款，以因应供应中断。

一套严谨的调查方法，说明资料收集、一手和二手检验、专家访谈以及检验，以确保分析的严谨性。

本分析采用混合调查方法，以确保研究结果的平衡性和检验。首先，对同行评审的临床文献、监管申报文件、医疗设备附加檔进行系统性的二次检索，以确定半刚性瓣环成形术成形术器械的临床和技术背景。其次，透过对心臟外科医生、采购人员、临床研究人员和监管专家进行结构化访谈，进行一手研究，以收集有关器械性能、推广障碍和区域采购惯例的经验性见解。

观点整合了临床、商业性和政策方面的见解，为相关人员在创新、伙伴关係和业务永续营运提供指南。

本报告综合的临床、商业性和政策证据表明，未来的半刚性环状成形术环必须满足严格的动态标准，同时适应不断变化的输送途径。在临床上，随着修復策略扩展到更多患者群体，能够简化植入过程并兼顾瓣膜动力学的器械设计仍然至关重要。在商业性，那些将临床结果与可证明的经济价值挂钩、投资于临床医生教育并采用反映当地采购实践的灵活分销和定价模式的公司将获得成功。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 半刚性环状成形术环市场（依材料类型划分）

  • 钴铬
  • 聚合物
  • 钛

第九章 半刚性环状成形术环市场：依应用划分

  • 二尖瓣修復
    • 主要介入措施
    • 二级干预
  • 三尖瓣修復
    • 主要介入措施
    • 二级干预

10. 按最终用户分類的半刚性环状成形术环市场

  • 门诊手术中心
  • 心臟诊所
    • 综合诊所
    • 独立心臟诊所
  • 医院
    • 私立医院
    • 公立医院

11. 各地区半刚性环状成形术环市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

12. 半刚性环状成形术环市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

13. 各国半刚性环状成形术环市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十四章 美国半刚性环环状成形术环市场

第十五章 中国半刚性环状成形术环市场

第十六章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • 4C Medical Technologies, Inc.
  • Abbott Laboratories
  • Anteris Technologies Ltd.
  • Boston Scientific Corporation
  • CardioMech AS
  • Cardiosolutions, Inc.
  • Coramaze Technologies GmbH
  • CryoLife, Inc.
  • Edwards Lifesciences Corporation
  • JenaValve Technology, Inc.
  • LivaNova PLC
  • Magenta Medical Ltd.
  • Medtronic plc
  • Medtronic, Inc.
  • Micro Interventional Devices, Inc.
  • Mitralign, Inc.
  • MValve Technologies Ltd.
  • Neovasc Inc.
  • Peijia Medical Limited
  • Suzhou Jiecheng Medical Co., Ltd.
  • Tendyne Holdings, Inc.
  • Xeltis AG
Product Code: MRR-867BED9A9EC7

The Semi-Rigid Annuloplasty Ring Market was valued at USD 305.02 million in 2025 and is projected to grow to USD 325.83 million in 2026, with a CAGR of 7.07%, reaching USD 492.31 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 305.02 million
Estimated Year [2026] USD 325.83 million
Forecast Year [2032] USD 492.31 million
CAGR (%) 7.07%

Semi-rigid annuloplasty rings occupy a critical role in contemporary valvular repair by providing the mechanical support and conformability required to restore annular geometry while preserving dynamic leaflet motion. During mitral and tricuspid valve repairs, these devices balance structural reinforcement with physiological flexibility, enabling surgeons to tailor repair strategies across degenerative, ischemic, and functional disease states. Over the past decade, clinicians have increasingly preferred repair approaches where feasible, driven by evidence favoring durable outcomes and preservation of native valve anatomy, which in turn places a premium on device design that harmonizes durability with hemodynamic performance.

From a commercial perspective, product development trends emphasize modularity, material science, and incremental innovations in delivery and implantation workflow. Manufacturers are responding to surgeon feedback with designs that simplify sizing and secure fixation while enabling minimally invasive access routes. As hospitals and cardiac centers adopt hybrid operating room models and invest in advanced imaging, device interoperability and procedural efficiency have emerged as differentiators. Consequently, understanding the clinical imperatives, procedural workflows, and stakeholder incentives that underpin device selection is essential for medical device teams, purchasing leaders, and clinical champions aiming to accelerate adoption and demonstrate value in complex care environments.

Transformative shifts in clinical practice, regulatory pathways, and device innovation that are changing repair strategies and the commercial outlook for annuloplasty rings

The landscape for semi-rigid annuloplasty rings is undergoing transformative shifts driven by converging clinical, technological, and policy forces. Minimally invasive surgical techniques and enhanced intraoperative imaging have expanded the candidate pool for repair procedures and changed the procedural ergonomics that ring designs must accommodate. Simultaneously, the maturation of transcatheter valve therapies and hybrid approaches has increased demand for devices that integrate with catheter-compatible workflows or complement percutaneous adjuncts. As a result, developers are prioritizing low-profile geometries, radiopaque markers, and compatibility with endoscopic and robotic platforms to align with evolving surgeon preferences.

Regulatory and reimbursement dynamics are also evolving, with authorities emphasizing real-world evidence, post-market surveillance, and value demonstration. Payers increasingly expect robust clinical and economic justification for device selection, which elevates the importance of prospective registries and health economics studies. Moreover, supply chain resilience and a shift toward strategic partnerships, including co-development and licensing arrangements, are reshaping how firms bring incremental innovations to market. Taken together, these shifts are redefining both clinical adoption curves and commercial strategies, making agility and evidence generation central to long-term competitiveness.

Cumulative effects of United States tariffs in 2025 on device supply chains, procurement economics, and strategic sourcing decisions for cardiac implant makers

The introduction and escalation of United States tariffs in 2025 created a cascade of operational and strategic impacts for manufacturers and suppliers involved in semi-rigid annuloplasty ring production. Tariff-driven cost pressures pushed procurement teams to re-evaluate component sourcing and origin-of-manufacture choices, incentivizing a mix of nearshoring, dual sourcing, and selective supplier consolidation to mitigate exposure. In parallel, manufacturers implemented inventory hedging and renegotiated long-term supply contracts to stabilize input costs and preserve margin integrity. These measures had second-order effects on lead times, with some organizations extending planning horizons and others accepting higher carrying costs to avoid assembly interruptions.

Beyond operational adjustments, tariffs influenced product roadmaps by prompting material substitution studies and design optimizations that reduce component complexity without sacrificing clinical performance. Regulatory teams confronted altered supplier landscapes and supply chain documentation requirements, increasing the emphasis on supplier qualification and traceability. Commercial teams faced pressure to articulate the value proposition of premium device features more clearly to justify any incremental price adjustments. Collectively, these dynamics accelerated strategic realignments across procurement, product development, and commercial operations, underscoring the need for scenario planning and adaptive contracting strategies.

Segmentation insights across clinical use, distribution routes, end-user profiles, and material selection that drive adoption, procurement, and device design

Segmentation analysis reveals distinct demand drivers and design priorities across clinical applications, distribution pathways, end-user environments, and material choices. Within application segmentation, mitral valve repair and tricuspid valve repair present different procedural complexities and clinical endpoints; mitral valve repair commonly differentiates between primary intervention and secondary intervention settings, and the same primary versus secondary distinction applies to tricuspid valve repair, which influences ring sizing algorithms, fixation strategies, and intraoperative instrumentation. These clinical layers affect both design specifications and surgeon training requirements, creating subsegments where ease of implantation or intraoperative adaptability becomes a decisive factor.

Distribution segmentation exposes the contrast between corporate direct sales and OEM direct sales under the direct sales umbrella, and between national distributors and regional distributors within distributor networks. Direct corporate and OEM channels enable tighter control over clinical education and pricing, whereas national and regional distributors offer broader geographic reach and local account management. End-user segmentation spans ambulatory surgical centers, cardiac clinics, and hospitals, and within clinics the split between multispecialty clinics and standalone cardiac clinics matters for procedural volume and device purchasing cycles; hospitals also vary between private and public institutions, each with different procurement protocols and capital approval processes. Material type segmentation-Cobalt-Chromium, Polymer, and Titanium-further layers product differentiation, with each material presenting trade-offs in stiffness, fatigue resistance, radiopacity, and cost that steer clinical preference and manufacturing choices. Integrating these segmentation dimensions helps firms target clinical claims, refine go-to-market strategies, and prioritize development efforts that align with distinct customer economics and procedural settings.

Regional dynamics and clinical infrastructure that influence commercialization and adoption across the Americas, EMEA, and Asia-Pacific healthcare markets

Regional dynamics shape clinical practice patterns, procurement norms, and the regulatory frameworks that device developers must navigate. In the Americas, procedural volume concentrations in tertiary cardiac centers and a strong private hospital sector influence adoption timing and the role of surgeon opinion leaders in technology diffusion. Meanwhile, supply chain networks and reimbursement models in North and Latin American markets create nuanced demand signals that developers must interpret to align training investments and commercial coverage strategies. Across Europe, Middle East & Africa, regulatory harmonization efforts coexist with country-specific health technology assessment processes, prompting firms to adopt differentiated evidence generation plans and localized market entry tactics.

In the Asia-Pacific region, the heterogeneity of healthcare infrastructure-from advanced university hospitals to rapidly expanding private systems-drives a bifurcated approach to commercialization that balances premium product positioning with cost-effective design options. Across all regions, investment in clinician education, registry participation, and local partnerships accelerates adoption. Moreover, regional capacity for minimally invasive and hybrid procedures, the pace of infrastructure modernization, and public policy priorities regarding domestic manufacturing and procurement all influence where and how manufacturers allocate R&D, manufacturing footprints, and commercial resources.

Competitive landscape and corporate strategies shaping innovation, partnership models, and manufacturing footprints of leading cardiac device developers

Leading companies in the semi-rigid annuloplasty ring domain are deploying complementary strategies that combine targeted R&D, selective M&A, and collaborative partnerships with clinical centers to accelerate evidence generation and surgical adoption. Firms investing in material science and iterative design improvements are increasingly differentiating through lower-profile devices, enhanced fixation systems, and features that streamline minimally invasive implantation. At the same time, strategic licensing agreements and OEM partnerships help some players scale manufacturing and extend distribution reach without incurring the full capital requirements of geographic expansion.

Competitive positioning also hinges on service and support capabilities: companies demonstrating comprehensive surgeon training programs, simulator-based education, and robust post-market surveillance arrangements tend to build stronger trust with high-volume centers and key opinion leaders. Manufacturing strategies differ as well, with some organizations prioritizing in-house precision metallurgy and others relying on contract manufacturers to optimize cost and capacity. Across the competitive set, success increasingly depends on the ability to link clinical outcomes to economic arguments, to sustain regulatory compliance across jurisdictions, and to adapt commercial models that reflect regional procurement practices and institutional purchasing cycles.

Actionable recommendations to help industry leaders align R&D, strengthen supply chains, and adapt commercial models to changing clinical and policy realities

Industry leaders should prioritize a set of pragmatic, actionable measures that align clinical value with operational resilience and commercial agility. First, advance evidence generation through focused prospective registries and collaborative investigator-led studies that address procedural endpoints most relevant to surgeons and payers; linking real-world outcomes to health economics narratives will strengthen contracting positions and payer negotiations. Second, diversify supplier bases and qualify alternative sources for critical components while exploring nearshoring options to reduce tariff and geopolitical exposure; contract structures should include volume-flex and contingency clauses to mitigate supply interruptions.

Third, optimize product portfolios by aligning material choices and device profiles with regional procedural mix and procurement sensitivities, ensuring that premium features are paired with clear clinical advantages. Fourth, invest in modular training programs and digital education platforms to accelerate surgeon proficiency in minimally invasive and hybrid approaches. Finally, adopt flexible commercial models-ranging from capital leasing to outcome-based arrangements-where appropriate, to lower adoption barriers and demonstrate shared risk with institutional customers. These steps collectively foster a resilient, evidence-led approach to growth and adoption in complex clinical environments.

Robust research methodology describing data collection, primary and secondary validation, expert interviews, and triangulation that ensure analytical rigor

This analysis integrates a mixed-method research methodology to ensure balanced, verifiable insights. The foundation includes systematic secondary research across peer-reviewed clinical literature, regulatory filings, device labeling, and procedural guidance documents, which established the clinical and technological context for semi-rigid annuloplasty devices. Complementing this, primary research comprised structured interviews with cardiac surgeons, procurement leaders, clinical researchers, and regulatory specialists to capture experiential perspectives on device performance, adoption barriers, and regional procurement practices.

Data synthesis relied on triangulation across sources, with iterative validation workshops involving clinician advisors and industry experts to reconcile divergent viewpoints and confirm practical relevance. The methodology emphasized transparency in source attribution, explicit documentation of assumptions, and sensitivity testing for alternative supply chain and reimbursement scenarios. Limitations include variability in reporting across institutions and evolving policy actions that may alter the strategic landscape; accordingly, conclusions prioritize robust, qualitative insights and recommended actions over speculative quantitative forecasts.

Concluding perspective synthesizing clinical, commercial, and policy insights to guide stakeholders on innovation, partnerships, and operational resilience

The combined clinical, commercial, and policy evidence synthesized in this report points to a future where semi-rigid annuloplasty rings must simultaneously satisfy demanding biomechanical criteria and adapt to shifting adoption pathways. Clinically, device designs that respect annular dynamics while enabling simplified implantation will maintain relevance as repair strategies are extended across patient populations. Commercially, success will favor firms that link clinical outcomes to demonstrable economic value, invest in clinician education, and deploy flexible distribution and pricing models that reflect regional procurement realities.

Operational resilience and a proactive approach to regulatory evidence generation will remain critical as tariff regimes, supplier footprints, and reimbursement frameworks continue to evolve. For stakeholders-manufacturers, hospital procurement teams, clinical leaders, and investors-the imperative is to combine rigorous clinical validation with adaptive commercial strategies and fortified supply chain planning to preserve continuity of care and sustain innovation momentum.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Semi-Rigid Annuloplasty Ring Market, by Material Type

  • 8.1. Cobalt-Chromium
  • 8.2. Polymer
  • 8.3. Titanium

9. Semi-Rigid Annuloplasty Ring Market, by Application

  • 9.1. Mitral Valve Repair
    • 9.1.1. Primary Intervention
    • 9.1.2. Secondary Intervention
  • 9.2. Tricuspid Valve Repair
    • 9.2.1. Primary Intervention
    • 9.2.2. Secondary Intervention

10. Semi-Rigid Annuloplasty Ring Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Cardiac Clinics
    • 10.2.1. Multispecialty Clinics
    • 10.2.2. Standalone Cardiac Clinics
  • 10.3. Hospitals
    • 10.3.1. Private Hospitals
    • 10.3.2. Public Hospitals

11. Semi-Rigid Annuloplasty Ring Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Semi-Rigid Annuloplasty Ring Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Semi-Rigid Annuloplasty Ring Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. United States Semi-Rigid Annuloplasty Ring Market

15. China Semi-Rigid Annuloplasty Ring Market

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025
  • 16.5. 4C Medical Technologies, Inc.
  • 16.6. Abbott Laboratories
  • 16.7. Anteris Technologies Ltd.
  • 16.8. Boston Scientific Corporation
  • 16.9. CardioMech AS
  • 16.10. Cardiosolutions, Inc.
  • 16.11. Coramaze Technologies GmbH
  • 16.12. CryoLife, Inc.
  • 16.13. Edwards Lifesciences Corporation
  • 16.14. JenaValve Technology, Inc.
  • 16.15. LivaNova PLC
  • 16.16. Magenta Medical Ltd.
  • 16.17. Medtronic plc
  • 16.18. Medtronic, Inc.
  • 16.19. Micro Interventional Devices, Inc.
  • 16.20. Mitralign, Inc.
  • 16.21. MValve Technologies Ltd.
  • 16.22. Neovasc Inc.
  • 16.23. Peijia Medical Limited
  • 16.24. Suzhou Jiecheng Medical Co., Ltd.
  • 16.25. Tendyne Holdings, Inc.
  • 16.26. Xeltis AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. UNITED STATES SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 11. CHINA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY COBALT-CHROMIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY COBALT-CHROMIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY COBALT-CHROMIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY POLYMER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY POLYMER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY POLYMER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY TITANIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY TITANIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY TITANIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY PRIMARY INTERVENTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY PRIMARY INTERVENTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY PRIMARY INTERVENTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY SECONDARY INTERVENTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY SECONDARY INTERVENTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY SECONDARY INTERVENTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY PRIMARY INTERVENTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY PRIMARY INTERVENTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY PRIMARY INTERVENTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY SECONDARY INTERVENTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY SECONDARY INTERVENTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY SECONDARY INTERVENTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY CARDIAC CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY CARDIAC CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY CARDIAC CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY CARDIAC CLINICS, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MULTISPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MULTISPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MULTISPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY STANDALONE CARDIAC CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY STANDALONE CARDIAC CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY STANDALONE CARDIAC CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. AMERICAS SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 59. AMERICAS SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY CARDIAC CLINICS, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY CARDIAC CLINICS, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY CARDIAC CLINICS, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY CARDIAC CLINICS, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY CARDIAC CLINICS, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY CARDIAC CLINICS, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY CARDIAC CLINICS, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY CARDIAC CLINICS, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 127. ASEAN SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 128. ASEAN SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY CARDIAC CLINICS, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 131. GCC SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GCC SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. GCC SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. GCC SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 135. GCC SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 136. GCC SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. GCC SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY CARDIAC CLINICS, 2018-2032 (USD MILLION)
  • TABLE 138. GCC SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPEAN UNION SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPEAN UNION SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPEAN UNION SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY CARDIAC CLINICS, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. BRICS SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. BRICS SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 151. BRICS SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 152. BRICS SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY CARDIAC CLINICS, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 155. G7 SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. G7 SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. G7 SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. G7 SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 159. G7 SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 160. G7 SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. G7 SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY CARDIAC CLINICS, 2018-2032 (USD MILLION)
  • TABLE 162. G7 SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 163. NATO SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. NATO SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. NATO SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. NATO SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 167. NATO SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 168. NATO SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. NATO SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY CARDIAC CLINICS, 2018-2032 (USD MILLION)
  • TABLE 170. NATO SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. UNITED STATES SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 173. UNITED STATES SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. UNITED STATES SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED STATES SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED STATES SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY CARDIAC CLINICS, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED STATES SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 180. CHINA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 181. CHINA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. CHINA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 183. CHINA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 184. CHINA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 185. CHINA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 186. CHINA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY CARDIAC CLINICS, 2018-2032 (USD MILLION)
  • TABLE 187. CHINA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)